Many of these gene flaws - there are plenty of them, with names like BCR-ABL - are relative newcomers to medical terminology, as are a majority of the new anti-tumor drugs, still in early testing, that are aimed at them. a- medical terminology, as are a majority of the new anti-tumor drugs, still in...